Figure 6.
Integrin αvβ3 mRNA levels association with TFs involved in TCL progression and clinical outcome of patients with TCL. (A-B) TF enrichment analysis using decoupleR 2.7. in TCL sample groups (GSE58445) with high and low ITGB3 and ITGAV levels. (C) Kaplan-Meier survival analysis was conducted using ggsurvfit 0.3.1 package in RStudio using R2 optimal cutoff expression. (D) Correlation analysis of the differentially expressed genes of interest with the OS of patients with TCL. OS, overall survival.